SLS (SELLAS Life Sciences Group) Institutional Ownership: 33.85% (As of Jun. 30, 2026)


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $14.71
! 1 Warning Sign
View Full Analysis

What is SELLAS Life Sciences Group Institutional Ownership?

SELLAS Life Sciences Group SLS -4.82% 25 Institutional Ownership is 33.85% as of Jun. 30, 2026. GuruFocus rates SLS with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SELLAS Life Sciences Group's institutional ownership is 33.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SELLAS Life Sciences Group's Insider Ownership is 2.18%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SELLAS Life Sciences Group's Float Percentage Of Total Shares Outstanding is 99.60%.

SELLAS Life Sciences Group Institutional Ownership Historical Data

* Premium members only.

The historical data trend for SELLAS Life Sciences Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SELLAS Life Sciences Group Institutional Ownership Chart

SELLAS Life Sciences Group Historical Data

The historical data trend for SELLAS Life Sciences Group can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 20.13 17.39 14.71 15.28 17.15 16.77 16.73 24.43 25.37 25.99
SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SELLAS Life Sciences Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 33.85% mean?
SELLAS Life Sciences Group (SLS) has a Institutional Ownership of 33.85% as of Jun. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on SELLAS Life Sciences Group and its competitors.
Is SELLAS Life Sciences Group's Institutional Ownership too high?
SELLAS Life Sciences Group's current Institutional Ownership is 33.85%. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's Institutional Ownership compare to MBX and BHVN?
SELLAS Life Sciences Group's Institutional Ownership of 33.85% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on SELLAS Life Sciences Group and its competitors. SELLAS Life Sciences Group's current Institutional Ownership is 33.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current Institutional Ownership of 33.85%. The current Institutional Ownership is 33.85%. SELLAS Life Sciences Group's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current Institutional Ownership is 33.85% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.71
Price